LABD

$7.34 1.52% $0.11
Sep 10, 2026 04:00 AM

LABD, or Direxion Daily S&P Biotech Bear 3X Shares, is an exchange-traded fund (ETF) designed to provide three times the inverse of the daily performance of the S&P Biotechnology Select Industry Index. LABD seeks to deliver -3x the daily return of the underlying index.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Sep 10, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Optimize Your LABD Trading Now

Unlock the full potential of LABD with OHLCX’s cutting-edge automated trading system. Our platform provides precise price action analysis, advanced technical indicators, and powerful quantitative algorithms. Enhance your market performance today and transform your trading experience today!

Maximize Results Now

Frequently Asked Questions

Key performance metrics for LABD include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. LABD targets -3x the daily performance of the S&P Biotechnology Select Industry Index.

LABD rebalances its holdings daily to maintain its -3x leverage ratio relative to the S&P Biotechnology Select Industry Index. This daily rebalancing ensures that the ETF remains aligned with its -3x daily performance target, though it can result in performance deviations over longer periods due to compounding effects.

Similar ETFs to LABD include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide 3x the daily performance of the S&P Biotechnology Select Industry Index, the opposite of LABD’s objective; XBI (SPDR S&P Biotech ETF), which provides exposure to the biotechnology sector without leverage; and BIB (Direxion Daily S&P Biotech Bull 2X Shares), which provides 2x the daily performance of the S&P Biotechnology Select Industry Index, less leveraged compared to LABD.

LABD has an expense ratio of approximately 1.07%. This fee covers the costs of managing the fund, including administrative and operational expenses, expressed as a percentage of the fund’s average net assets.

Yes, LABD can be held in retirement accounts such as IRAs or 401(k)s. However, due to its high-risk, leveraged nature, it is essential to consider how it fits within your overall investment strategy and risk tolerance.

LABD typically distributes dividends on a quarterly basis. These dividends come from income generated by the underlying securities, although leveraged ETFs like LABD may have lower yields compared to non-leveraged funds.

Historical performance data for LABD includes past returns, NAV, and volatility. Investors should review performance charts and reports to understand LABD's track record in achieving its leveraged inverse objective.

Factors influencing LABD’s performance include movements in the biotech sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. LABD’s daily rebalancing and compounding effects also impact performance.

LABD uses leverage to amplify its inverse exposure to the biotech sector, targeting -3x the daily performance of the S&P Biotechnology Select Industry Index. Leverage can lead to significant performance fluctuations, particularly over periods longer than one day due to compounding effects.

Risks include high volatility and potential for significant losses due to LABD’s leveraged inverse exposure. The ETF's performance is highly sensitive to daily movements in the biotech sector, and leverage can amplify both gains and losses.

Transform Your LABD Trading Now

Experience the future of trading with ohlcx.com. Our advanced system delivers in-depth analysis and insights for LABD, utilizing state-of-the-art technical tools and strategies. Transform your trading strategy now and see how we can elevate your trading results!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.